Premium
The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey
Author(s) -
Litman Heather J.,
McKinlay John B.
Publication year - 2007
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2007.07018.x
Subject(s) - prostatitis , medicine , population , disease , health care , gerontology , lower urinary tract symptoms , demography , environmental health , prostate , cancer , economics , economic growth , sociology
OBJECTIVE To use the population‐based data from the Boston Area Community Health (BACH) Survey to estimate the likely magnitude (prevalence) of urological symptoms in the USA population in 2025, as health‐services researchers use projections of the likely magnitude of disease to inform decisions on the future allocation of health resources. METHODS Age and gender‐specific prevalence rates from BACH were combined with USA population projections to estimate the likely magnitude of lower urinary tract symptoms (LUTS) and symptoms suggestive of urine leakage, painful bladder syndrome (PBlS) and prostatitis (men only). RESULTS In total and accounting for overlapping symptoms, 52 million adults in the USA will have symptoms of LUTS, urine leakage, PBlS or prostatitis in 2025. These urological symptoms have a large impact on physical and mental aspects of quality of life, that is comparable to other chronic conditions. CONCLUSIONS The future magnitude of symptoms indicative of these four urological conditions might reach the current level of cardiovascular disease in the USA, which is considered ‘a modern epidemic.’ Our projections have important implications for medical education, training of healthcare providers, health‐services research, and policy and patient education.